Bio-Technology General Euflexxa 1% Sodium Hyaluronate

Country: Singapúr

Tungumál: enska

Heimild: HSA (Health Sciences Authority)

Fáanlegur frá:

FERRING PHARMACEUTICALS PRIVATE LIMITED

Tegund:

Class D medical device

Framleitt af:

Bio-Technology General (Israel) Ltd.

Lækningarsvæði:

Orthopaedics

Ábendingar:

EUFLEXXA is indicated for the treatment of pain caused by osteoarthritis of the knee, hip, temporomandibular, carpometacarpal, shoulder and ankle joints. EUFLEXXA aids in lubrication of the joint, allows for greater mobility and flexibility of the treated joint, and reduces pain in the affected joint.

Vörulýsing:

Device System Info:[Sterile Medical Device], EUFLEXXA is packed in a single-use, aseptically-filled disposable sterile 2.25 ml syringe (nominal volume) containing either 1 ml or 2 ml of 1% microbial fermentation-derived NaHA in phosphate-buffered saline; Models: Euflexxa 1% Sodium Hyaluronate - 3 x 2ml, Euflexxa 1% Sodium Hyaluronate - 1 x 2ml

Leyfisdagur:

2017-04-28